Cancer drugs undergo rigorous clinical trials before they are approved for use. These trials aim to ensure the drug's efficacy and safety. Post-approval, the drugs are continually monitored through pharmacovigilance programs to detect any adverse effects. Healthcare providers and patients can report side effects, which helps regulatory bodies monitor the drug's safety profile.
